NASDAQ · Price History

Generate Biomedicines, Inc. (GENB) Stock Price History & Returns

$9.84 NASDAQ: GENB Market Cap $1.27B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Generate Biomedicines, Inc. (GENB) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $9.84 sits 0% of the way up a 52-week range of $9.84 to $22.67; 56.6% below the 52-week high; below its 50-day moving average of $14.56; below its 200-day average of $14.05; a beta of -0.14 means it has historically moved opposite the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-22.8%
6 months-24.6%

Monthly closing prices

The last 10 months, newest first. 4 of 9 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$9.84-32.0%
October 2026$14.46-3.7%
September 2026$15.02-1.6%
August 2026$15.27+9.1%
July 2026$14.00-17.0%
June 2026$16.87+28.6%
May 2026$13.12+3.9%
April 2026$12.63+1.0%
March 2026$12.50-1.2%
February 2026$12.65—

Generate Biomedicines, Inc. (GENB) price history — frequently asked questions

How has Generate Biomedicines, Inc. performed over the last year?

Generate Biomedicines, Inc. (GENB) has risen 0.0% over the last twelve months, measured on price alone.

What is Generate Biomedicines, Inc.'s five-year return?

Over five years the GENB share price has gained 0.0%, excluding dividends.

What is Generate Biomedicines, Inc.'s 52-week range?

Over the last year Generate Biomedicines, Inc. (GENB) has traded between $9.84 and $22.67.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.